To the Editor The article by Ibrahim et al1 concerning reoperation and Medicare expenditures for laparoscopic adjustable gastric banding (AGB) is interesting, and I commend the authors for their examination of long-term population-level data in an effort to better understand outcomes. However, I must respectfully disagree with their conclusion that payers should reconsider coverage based on value and questionable safety and effectiveness.